These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 25080557

  • 1. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen.
    Bailón E, Ugarte-Berzal E, Amigo-Jiménez I, Van den Steen P, Opdenakker G, García-Marco JA, García-Pardo A.
    J Leukoc Biol; 2014 Aug; 96(2):185-99. PubMed ID: 25080557
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen.
    Bailón E, Ugarte-Berzal E, Amigo-Jiménez I, Van den Steen P, Opdenakker G, García-Marco JA, García-Pardo A.
    J Leukoc Biol; 2014 Mar 11. PubMed ID: 24620030
    [Abstract] [Full Text] [Related]

  • 3. A catalytically inactive gelatinase B/MMP-9 mutant impairs homing of chronic lymphocytic leukemia cells by altering migration regulatory pathways.
    Bailón E, Aguilera-Montilla N, Gutiérrez-González A, Ugarte-Berzal E, Van den Steen PE, Opdenakker G, García-Marco JA, García-Pardo A.
    Biochem Biophys Res Commun; 2018 Jan 01; 495(1):124-130. PubMed ID: 29080742
    [Abstract] [Full Text] [Related]

  • 4. Editorial: pro-matrix metalloproteinase-9 in tumor B lymphocytes: balancing migration and homing.
    Bauvois B.
    J Leukoc Biol; 2014 Aug 01; 96(2):164-6. PubMed ID: 25080556
    [No Abstract] [Full Text] [Related]

  • 5. MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest.
    Aguilera-Montilla N, Bailón E, Uceda-Castro R, Ugarte-Berzal E, Santos A, Gutiérrez-González A, Pérez-Sánchez C, Van den Steen PE, Opdenakker G, García-Marco JA, García-Pardo A.
    Oncogene; 2019 Jun 01; 38(23):4605-4619. PubMed ID: 30760844
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
    Hartmann TN, Grabovsky V, Wang W, Desch P, Rubenzer G, Wollner S, Binsky I, Vallon-Eberhard A, Sapoznikov A, Burger M, Shachar I, Haran M, Honczarenko M, Greil R, Alon R.
    Cancer Res; 2009 Apr 01; 69(7):3121-30. PubMed ID: 19293181
    [Abstract] [Full Text] [Related]

  • 8. Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain.
    Redondo-Muñoz J, Ugarte-Berzal E, Terol MJ, Van den Steen PE, Hernández del Cerro M, Roderfeld M, Roeb E, Opdenakker G, García-Marco JA, García-Pardo A.
    Cancer Cell; 2010 Feb 17; 17(2):160-72. PubMed ID: 20159608
    [Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide.
    Amigo-Jiménez I, Bailón E, Ugarte-Berzal E, Aguilera-Montilla N, García-Marco JA, García-Pardo A.
    PLoS One; 2014 Feb 17; 9(6):e99993. PubMed ID: 24956101
    [Abstract] [Full Text] [Related]

  • 10. Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells.
    Redondo-Muñoz J, Ugarte-Berzal E, García-Marco JA, del Cerro MH, Van den Steen PE, Opdenakker G, Terol MJ, García-Pardo A.
    Blood; 2008 Jul 01; 112(1):169-78. PubMed ID: 18326820
    [Abstract] [Full Text] [Related]

  • 11. Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model.
    Aydin S, Grabellus F, Eisele L, Möllmann M, Hanoun M, Ebeling P, Moritz T, Carpinteiro A, Nückel H, Sak A, Göthert JR, Dührsen U, Dürig J.
    Eur J Haematol; 2011 Jul 01; 87(1):10-9. PubMed ID: 21692849
    [Abstract] [Full Text] [Related]

  • 12. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
    Cuesta-Mateos C, López-Giral S, Alfonso-Pérez M, de Soria VG, Loscertales J, Guasch-Vidal S, Beltrán AE, Zapata JM, Muñoz-Calleja C.
    Exp Hematol; 2010 Sep 01; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
    [Abstract] [Full Text] [Related]

  • 13. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Chinni SR, Sivalogan S, Dong Z, Filho JC, Deng X, Bonfil RD, Cher ML.
    Prostate; 2006 Jan 01; 66(1):32-48. PubMed ID: 16114056
    [Abstract] [Full Text] [Related]

  • 14. Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells.
    Ringshausen I, Dechow T, Schneller F, Weick K, Oelsner M, Peschel C, Decker T.
    Leukemia; 2004 Dec 01; 18(12):1964-70. PubMed ID: 15483673
    [Abstract] [Full Text] [Related]

  • 15. Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.
    Hofbauer SW, Piñón JD, Brachtl G, Haginger L, Wang W, Jöhrer K, Tinhofer I, Hartmann TN, Greil R.
    Cancer Res; 2010 Sep 15; 70(18):7336-44. PubMed ID: 20823161
    [Abstract] [Full Text] [Related]

  • 16. A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
    Dürig J, Ebeling P, Grabellus F, Sorg UR, Möllmann M, Schütt P, Göthert J, Sellmann L, Seeber S, Flasshove M, Dührsen U, Moritz T.
    Cancer Res; 2007 Sep 15; 67(18):8653-61. PubMed ID: 17875705
    [Abstract] [Full Text] [Related]

  • 17. IL-1 beta induces proMMP-9 expression via c-Src-dependent PDGFR/PI3K/Akt/p300 cascade in rat brain astrocytes.
    Wu CY, Hsieh HL, Sun CC, Tseng CP, Yang CM.
    J Neurochem; 2008 May 15; 105(4):1499-512. PubMed ID: 18315570
    [Abstract] [Full Text] [Related]

  • 18. Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia.
    Benkisser-Petersen M, Buchner M, Dörffel A, Dühren-von-Minden M, Claus R, Kläsener K, Leberecht K, Burger M, Dierks C, Jumaa H, Malavasi F, Reth M, Veelken H, Duyster J, Zirlik K.
    PLoS One; 2016 May 15; 11(12):e0169159. PubMed ID: 28036404
    [Abstract] [Full Text] [Related]

  • 19. Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons.
    Bauvois B, Dumont J, Mathiot C, Kolb JP.
    Leukemia; 2002 May 15; 16(5):791-8. PubMed ID: 11986939
    [Abstract] [Full Text] [Related]

  • 20. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK, Hwang YS, Park KK, Park HJ, Seo JY, Chung WY.
    Carcinogenesis; 2009 Jul 15; 30(7):1225-33. PubMed ID: 19420016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.